
Drug delivery shapes how patients experience treatment. Biotts exists to advance therapeutic delivery that is practical and patient-friendly – through our proprietary transdermal platform and the R&D services we provide to pharmaceutical and biotech partners. Our values define how we approach this work: the standards we uphold, the relationships we build, and the outcomes we pursue.
Scientific Rigor — We make decisions based on measurable results, designing studies with clear objectives, appropriate controls, and transparent reporting so partners can act with confidence.
Quality & Compliance — We operate from a GMP-certified R&D facility, generating documentation suitable for regulatory submissions with validated methods and traceability across key development steps.
Partnership & Collaboration — We function as an extension of partner teams, managing scope, timelines, and escalation proactively with clear communication at every stage.
Innovation & R&D Excellence — Developing the MTC-Y™ platform required advancing transdermal delivery of challenging molecules, including peptides, across lipophilic and hydrophilic profiles. We maintain this commitment across all formulation and analytical programs.
Patient-Centered Delivery — We design with the end user in mind, focusing on non-invasive formats that reduce dosing burden and may support adherence, improving how patients experience treatment.
Our mission is to develop transdermal drug candidates using the MTC-Y™ carrier platform and provide formulation and analytical R&D services that generate decision-grade data for pharmaceutical and biotech partners. Our vision is to advance patient-friendly drug delivery by expanding the scientific and commercial viability of transdermal therapeutics, enabling partners to bring better treatment options to patients with greater confidence.